With rare exceptions like the oral polio vaccine and intranasal vaccines against influenza, the majority of immunizations are ...

When children receive their second dose of the measles-mumps-rubella vaccine between 4 and 6 years, the protection against ...

JCU researchers have found particles in the popular "superfood" Spirulina that could lead to significant advancements in ...

Blood samples collected at a dozen time points during the first 100 days after vaccination took stock of all the genes, ...

Not all vaccines are created equal – some give us lifelong protection from disease after a short course, while others need a ...

The U.S. Centers for Disease Control and Prevention (CDC) currently recommends that everyone 75 and older receive a single ...

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.

All five patients chose to omit adjuvant chemotherapy. Justin Balko, PharmD, PhD, of the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, told MedPage Today that other immune biomarkers ...

Researchers concluded that dabrafenib and trametinib appeared active in the second-line adjuvant setting, “although more follow up is required to confirm.” ...

A new blood test can predict how long vaccine immunity will last. The revolutionary breakthrough will help to create more ...

"We suspected that a fundamental difference in the two vaccines -- the presence or absence of an immune-stimulating chemical called an adjuvant -- might play a role in the variance in immunity ...